Our results showed that when combined with BiTE, T cells carrying CD3εζ28 had better killing effects on tumor cells and expressed higher levels of IL-2 and IFN-γ and the genes related to T cell activation than normal T cells. This evidence concerns the gene IFNG and neoplasm.